At Kyowa Kirin we are committed to maintaining the highest standards of transparency and ethics with regards to all our business practices. Collaborations with healthcare professionals (HCPs) and healthcare organisations (HCOs) is based upon supporting improvements in the quality of care for all patients.  In accordance with industry standards, Kyowa Kirin is pleased to publish full details of transfers of value associated with these collaborations.The transparency disclosure reports below outline transfers of value to: i) HCPs registered to practice in the UK & Ireland; ii) HCOs, iii) Patient Organisations (POs) in UK & Ireland; and iv) members of the public including patients and journalists. Disclosure reports relevant to other countries may be accessed via the links for these countries’ webpages on the home page of this website.

Effective from 1 January 2023, Kyowa Kirin no longer relies on written consent from HCPs but instead use Legitimate Interest as the legal basis of processing and disclosing transfer of value information. This ensures our commitment to maintaining the highest level of transparency.

Kyowa Kirin publishes this information on or around the 30 June covering the previous calendar year.

Enquires can be addressed to kki_compliance_northerncluster@kyowakirin.com

Please find below the transfer of value disclosure information required.